Search Results
Results found for "Maria Waldhoer"
Posts (12)
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Our CSO, Maria, has recently traveled to the US to attend the ACSMEDI-EFMC Medicinal Chemistry Frontiers The venue was the UIC Student Center East, and Chicago is a great choice for a city, Maria found it very Wednesday was a key day for Maria, as she got to participate in a panel discussion alongside Dr. Maria alongside the other panelists during Wednesday's panel discussion. Session 8 on Thursday was Maria’s turn to give a talk.
- 📰 GPCR Weekly News, May 6 to 12, 2024
Maria Waldhoer, JoAnn Trejo, and Anne Marie Quinn. Did you watch Episode #150Â of the Dr.
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
Maria Majellaro makes it clear that Celtarys isn’t just a ligand provider. Maria Majellaro Celtarys specializes in the custom development of fluorescent ligands  using a modular Maria emphasizes the importance of genuinely listening to researchers: understanding the biological question Maria Majellaro Now, as official partners of the Dr.
Other Pages (9)
- Dr. Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias | Dr. GPCR Ecosystem
Maria Waldhoer on why endpoint GPCR assays miss most of what ligands do — and what kinetic pharmacological Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias Dr. Maria Waldhoer is Chief Scientific Officer at InterAx Biotech AG in Switzerland. Maria Waldhoer is originally from Austria. Maria Waldhoer on the web LinkedIn InterAx Biotech Pubmed Dr.
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
Maria Waldhoer is Chief Scientific Officer at InterAx Biotech in Switzerland. Maria Waldhoer "In 1989, as a med student in Romania, I used BASIC to model the variation in heart rate Maria Waldhoer About this episode Listen to this fantastic round table discussion that I had the privilege Our guests were Maria Waldhoer , Tudor I.
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
Maria Waldhoer at the Medical University of Graz, Austria, and received my Ph.D. in Molecular Medicine





